(Press-News.org) (SACRAMENTO, Calif.) — When public health budgets are constrained, mammography screening should begin later and occur less frequently, a cost-effectiveness analysis for California's Every Woman Counts (EWC) program concludes.
As outlined in a paper published in Value in Health, the analysis focused on several policy questions, including the effect on EWC program costs and outcomes of starting screening at age 50 years instead of 40 and of screening every two years instead of every year. The study was conducted in response to recent government funding cutbacks.
"This was not a clinical recommendation, but rather was intended to help a public health program use its resources to the greatest effectiveness," said lead author Joy Melnikow, director of the UC Davis Center for Healthcare Policy and Research.
EWC, administered through the California Department of Public Health Cancer Detection Section, is one of the largest of 68 Centers for Disease Control and Prevention-funded programs across the country. It reimburses providers at Medi-Cal rates (Medi-Cal is the California version of Medicaid) for screening and diagnostic services for breast and cervical cancers. It provides services to women who are not eligible for Medi-Cal, who otherwise lack coverage for breast and cervical cancer screening, and whose income is less than 200 percent of the federal poverty threshold.
The study, conducted by UC Davis and EWC researchers, was based on a sophisticated microsimulation model that projected outcomes based on existing program data. It found that starting mammography screening biennially at age 50 was strongly supported by the model results, given that program funding did not allow screening of the full population of eligible women beginning at age 40.
"Because breast cancer incidence goes up with age, using program funds to screen all eligible women over age 50 will have a greater impact on reducing breast cancer deaths," said Melnikow. "The goal was to advise a public health program in a timeframe that could be helpful, given that cost-effectiveness analysis typically takes a long time to conduct — often too long to be of use in a quickly changing policy environment."
The United States Preventive Services Task Force, a government medical task force, in 2009 recommended the same changes in breast cancer screening guidelines, suggesting that most women should not begin getting routine mammograms until age 50, and then only once every two years.
"The task force was asking a different question," explains Melnikow, who became a member of the task force after the breast cancer screening recommendations vote. "In that case, cost-effectiveness and policy weren't factors. Instead, the Task Force looked at recommendations for screening of women exclusively from a clinical point of view."
Melnikow, a UC Davis professor of Family and Community medicine, points out that the EWC analysis has implications for other budget-constrained public programs around the country.
"This study is important for administrators who are doing their best to run public health programs with limited resources. We found that, although it can be challenging, it is by no means impossible to create carefully constructed cost-effectiveness analysis models quickly enough to be useful to programs and policy makers as they render important resource allocation decisions."
INFORMATION:
Other study authors were Daniel J. Tancredi, Zhuo Yang, Dominique Ritley, Yun Jiang and Christina Slee, all of the UC Davis Center for Healthcare Policy and Research, UC Davis; and Svetlana Popova, Phillip Rylett, Kirsten Knutson and Sherie Smalley, of the Every Woman Counts program, Cancer Detection Section.
Funding for the study was provided by the California Program on Access to Care , UC Berkeley School of Public Health in cooperation with the UC Office of the President.
The Center for Health Policy Research conducts research on health-care access, delivery, costs, outcomes and related health policy to improve the organization, quality and effectiveness of the practice of medicine, especially primary care. The center is a resource for the university and health system on comparative effectiveness research. Center faculty conduct original research, offer consulting services to agencies in both public and private sectors, and provide research training to fellows, graduate students and junior faculty. Established as an interdisciplinary unit, the center includes more than 80 health-care researchers who represent disciplines ranging from business management and psychiatry to preventive medicine, epidemiology and statistics. For more information, visit http://www.ucdmc.ucdavis.edu/chpr.
END
When a person has cancer, some of the cells in his or her body have changed and are growing uncontrollably. Most cancer drugs try to treat the disease by killing those fast-growing cells, but another approach called immunotherapy tries to stimulate a person's own immune system to attack the cancer itself.
Now, scientists at the University of Washington have developed a strategy to slow tumor growth and prolong survival in mice with cancer by targeting and destroying a type of cell that dampens the body's immune response to cancer. The researchers published their findings ...
Hospitalizations for endocarditis, a deadly heart infection that disproportionately affects older heart patients, have declined in recent years despite recommendations for limited use of antibiotics to prevent the illness. These findings were recently published by Yale School of Medicine researchers in the Journal of the American College of Cardiology.
Endocarditis is the most serious infection of the cardiovascular system, and the risk increases with surgical procedures. Past studies showed a marked increase in endocarditis hospitalization rates during the 1990s. As ...
HOUSTON – (Sept. 16, 2013) – A "vicious cycle" produces mucus that protects uterine and pancreatic cancer cells and promotes their proliferation, according to researchers at Rice University. The researchers offer hope for a therapeutic solution.
They found that protein receptors on the surface of cancer cells go into overdrive to stimulate the production of MUC1, a glycoprotein that forms mucin, aka mucus. It covers the exposed tips of the elongated epithelial cells that coat internal organs like lungs, stomachs and intestines to protect them from infection.
But when ...
AUDIO:
Researchers from around the world, led by scientists at the Genome Institute at Washington University School of Medicine and the University of Michigan School of Public Gealth, have identified a...
Click here for more information.
An international team of researchers, led by scientists at The Genome Institute at Washington University School of Medicine in St. Louis and the University of Michigan School of Public Health in Ann Arbor, has identified a gene mutation ...
The risk of death following bone marrow transplantation can be reduced about 60 percent using a new technique to identify bone marrow donors who make the most potent cancer-fighting immune cells, according to research from St. Jude Children's Research Hospital. The findings appear in the September 16 online issue of the Journal of Clinical Oncology.
The research builds on an earlier St. Jude discovery that specialized immune cells called natural killer (NK) cells dispatched cancer cells more efficiently when the NK cells carried a particular version of a KIR protein on ...
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.
Sickle cell disease is an inherited condition in which the body makes red blood cells containing abnormal hemoglobin, the protein that carries oxygen from the lungs to other cells in the body. This abnormal hemoglobin (hemoglobin S) causes ...
Troy, N.Y. – A computational model developed by researchers at Rensselaer Polytechnic Institute is the first to accurately simulate the complex twists of a short sequence of RNA as it folds into a critical hairpin structure known as a "tetraloop." The research, published today in Proceedings of the National Academy of Sciences, is a glimpse into RNA, found in all life on Earth, and could advance a variety of research areas, including the search for new antibiotics and cures for protein-related diseases.
Existing computational models, based on DNA rather than RNA, do not ...
Reliable quantum computing would make it possible to solve certain types of extremely complex technological problems millions of times faster than today's most powerful supercomputers. Other types of problems that quantum computing could tackle would not even be feasible with today's fastest machines. The key word is "reliable." If the enormous potential of quantum computing is to be fully realized, scientists must learn to create "fault-tolerant" quantum computers. A small but important step toward this goal has been achieved by an international collaboration of researchers ...
COLUMBUS, Ohio – New research shows that microRNA-486 is a potent tumor-suppressor molecule in lung cancer, and that the it helps regulate the proliferation and migration of lung-cancer cells, and the induction of programmed cell death, or apoptosis, in those cells.
The preclinical study was led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). It found that microRNA-486 (miR-486) directly targets the insulin growth-factor pathway, which is important for ...
This news release is available in French.
Montreal September 17, 2013 – Chest pain is recognized as a symptom of heart troubles, but one out of five women aged 55 years or less having a heart attack do not experience this symptom, according to a study led by the Research Institute of the McGill University Health Centre (RI-MUHC). The research findings, gathered from partner institutions across Canada including the University of British Columbia (UBC), are the first to describe this phenomenon in young women. The study, published in JAMA Internal Medicine, has ...
